Retinal ganglion cell degeneration underlies several conditions which give rise to significant visual compromise, including glaucoma, hereditary optic neuropathies, ischaemic optic neuropathies, and demyelinating disease. In this review, we discuss the emerging strategies for neuroprotection specifically in the context of glaucoma, including pharmacological neuroprotection, mesenchymal stem cells, and gene therapy approaches. We highlight potential pitfalls that need to be considered when developing these strategies and outline future directions, including the prospects for clinical trials.
CITATION STYLE
Khatib, T. Z., & Martin, K. R. (2017). Protecting retinal ganglion cells. In Eye (Basingstoke) (Vol. 31, pp. 218–224). Nature Publishing Group. https://doi.org/10.1038/eye.2016.299
Mendeley helps you to discover research relevant for your work.